These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15582140)

  • 1. Liver involvement in cystic fibrosis: primary organ damage or innocent bystander?
    Colombo C; Battezzati PM
    J Hepatol; 2004 Dec; 41(6):1041-4. PubMed ID: 15582140
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk factors for the development of cystic fibrosis related liver disease.
    Slieker MG; Deckers-Kocken JM; Uiterwaal CS; van der Ent CK; Houwen RH
    Hepatology; 2003 Sep; 38(3):775-6; author reply 776-7. PubMed ID: 12939606
    [No Abstract]   [Full Text] [Related]  

  • 3. Modifier genes and cystic fibrosis liver disease.
    Pirzada O; Taylor C
    Hepatology; 2003 Mar; 37(3):714; author reply 714. PubMed ID: 12601371
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatobiliary disease in patients with cystic fibrosis.
    Moyer K; Balistreri W
    Curr Opin Gastroenterol; 2009 May; 25(3):272-8. PubMed ID: 19381084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hepatobiliary disorders in cystic fibrosis].
    van de Meeberg PC; Bijleveld CM; Heijerman HG; Houwen RH; Sinaasappel M; van Berge Henegouwen GP
    Ned Tijdschr Geneeskd; 1994 Jul; 138(27):1357-60. PubMed ID: 8035893
    [No Abstract]   [Full Text] [Related]  

  • 6. Liver disease in cystic fibrosis.
    Colombo C
    Curr Opin Pulm Med; 2007 Nov; 13(6):529-36. PubMed ID: 17901760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary prognosis in cystic fibrosis patients with liver disease.
    Slieker MG; van der Doef HP; Deckers-Kocken JM; van der Ent CK; Houwen RH
    J Pediatr; 2006 Jul; 149(1):144; author reply 144-5. PubMed ID: 16860146
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cystic fibrosis: current therapy. Diagnosis and treatment of hepatobiliary diseases].
    Spalinger J
    Schweiz Med Wochenschr Suppl; 2000; 122():17S-21S. PubMed ID: 12536465
    [No Abstract]   [Full Text] [Related]  

  • 9. Liver transplantation for metabolic liver diseases.
    Zhang KY; Tung BY; Kowdley KV
    Clin Liver Dis; 2007 May; 11(2):265-81. PubMed ID: 17606206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Liver manifestations of mucoviscidosis].
    Dietzsch HJ; Gottschalk B; Hinkel GK
    Kinderarztl Prax; 1980; 48(4):169-75. PubMed ID: 6106728
    [No Abstract]   [Full Text] [Related]  

  • 11. [Liver and mucoviscidosis].
    Lacaille F
    Gastroenterol Clin Biol; 1997; 21(8-9):607-18. PubMed ID: 9587499
    [No Abstract]   [Full Text] [Related]  

  • 12. Screening for liver disease in cystic fibrosis: analysis of clinical and genetic risk factors for its development.
    Fustik S; Trajkovska M; Jakovska T; Spirevska L; Josifovska T; Koceva S
    Turk J Pediatr; 2008; 50(6):526-32. PubMed ID: 19227414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver involvement in cystic fibrosis.
    Colombo C; Crosignani A; Battezzati PM
    J Hepatol; 1999 Nov; 31(5):946-54. PubMed ID: 10580595
    [No Abstract]   [Full Text] [Related]  

  • 14. Liver disease in cystic fibrosis.
    Colombo C; Russo MC; Zazzeron L; Romano G
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S49-55. PubMed ID: 16819402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful liver transplantation using the liver of donors with cystic fibrosis.
    Aljebreen AR; Deschênes M; Lilly L; Metrakos P
    Hepatology; 2003 Oct; 38(4):1059; discussion 1059-60. PubMed ID: 14512894
    [No Abstract]   [Full Text] [Related]  

  • 16. [Question 5. What management in hepatobiliary injury in the course of cystic fibrosis? Specific therapeutic strategy of hepatobiliary injury in the course of cystic fibrosis].
    Debray D
    Arch Pediatr; 2003 Aug; 10 Suppl 3():490s-494s. PubMed ID: 14671965
    [No Abstract]   [Full Text] [Related]  

  • 17. Markers of cystic fibrosis-associated liver disease.
    Narkewicz MR
    J Pediatr Gastroenterol Nutr; 2001 Apr; 32(4):421-2. PubMed ID: 11396806
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatolithiasis in cystic fibrosis: a special condition for surgical treatment.
    Mon Martín F; Martín Malagón AI; Arteaga González IJ; Díaz Luís H; Carrillo Pallares AL
    Cir Esp; 2014 Nov; 92(9):634-5. PubMed ID: 24361100
    [No Abstract]   [Full Text] [Related]  

  • 19. Prognosis in cystic fibrosis.
    Williams SG; Hayller KM; Hodson ME; Westaby D
    N Engl J Med; 1992 Oct; 327(17):1244-5. PubMed ID: 1406813
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mucoviscidosis of the adult and liver insufficiency].
    Carboni M; Benedetti-Valentini F; Patrassi N
    Epatologia; 1970; 16(5):465-8. PubMed ID: 5525654
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.